Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX
Integrated with the company’s industry-leading site payment technology, the new solution delivers efficiency and accuracy to support a streamlined and optimized study start-up
KING OF PRUSSIA, Pa. – June 2, 2020 – Greenphire, the global leader in financial lifecycle management for clinical trials, today announced the launch of EnvisiX to address the budgeting challenges experienced by global sponsors and CROs during study start-up. The new budget development solution streamlines trial initiation for sponsors and CROs and eliminates guesswork during the budgeting process to deliver a smarter, more efficient workflow.
EnvisiX seamlessly integrates with eClinicalGPS, Greenphire’s industry-leading site payment solution, enabling unprecedented simplicity and efficiency throughout a trial from budget creation and negotiation to management, execution, and tracking of global investigator grants.
“Greenphire is dedicated to engineering workflow and data solutions that transform business processes, reducing administrative burden and improving process effectiveness at each step of the clinical trial,” said Jim Murphy, Greenphire CEO. “With EnvisiX, stakeholders gain visibility and control over historically manual and fragmented budget build and negotiation workflows, ensuring improved speed and accuracy along the way.”
EnvisiX will enable sponsors and CROs to:
- Have access to the most robust and contemporary investigator grant payment data in the industry
- Simplify and streamline the budget creation and negotiation workflow for improved collaboration, transparency and management of rates, adjustments, adjudications, approvals and more
- Benefit from an integration with the industry leading site payment solution, eClinicalGPS, providing a unified workflow from budget build and negotiation through payment execution and analysis
- Access expert teams of local negotiators with country-level budget knowledge and international lawyers providing in-country consultation and regulatory oversight and guidance
- Achieve or beat ‘First Patient In’ milestone targets by eliminating administrative burden and reducing cycle times
“For years, sponsors and CROs have expressed dissatisfaction with their study start-up processes. We have developed EnvisiX as a direct response to frustrations with the current workflows and solutions available in the market today,” said Kyle Cunningham, Chief Product Officer at Greenphire. “Our mission was to ensure that EnvisiX provides our customers with a streamlined and user friendly experience for building a budget and ultimately to enable maximized confidence, defensibility and end-to-end efficiency via a direct integration and feedback loop with eClinicalGPS, the industry’s leading site payment solution.”
To learn more about EnvisiX, visit us at https://greenphire.com/budgeting/.
Presentation Information: Greenphire at DIA 2020 Virtual Meeting
Murphy will Chair the on-demand session “Optimizing Study Start Up Processes: Site Selection, Budgeting & Contracting” at the DIA 2020 Virtual Meeting beginning on June 14. To attend, visit https://bit.ly/2SXq0yr.
Greenphire is the leader in global clinical trial financial process automation. Greenphire’s best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphire’s EnvisiX, eClinicalGPS, ClinCard and ConneX solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and simplified travel globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.